Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early extra MMR vaccination in infants during a measles outbreak
NL-OMON44694Phase 4Active, not recruiting
- Sponsor
- National Institute for Public Health and the Environment
- Start
- Oct 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of measles, mumps, and rubella vaccine in measles (2 arms), sponsored by National Institute for Public Health and the Environment. Primary endpoints: Measles-specific B-cell immunogenicity, Measles-specific T-cell immunogenicity and 3 more. Started Oct 2013; status: active, not recruiting.
02
Drugs
measles, mumps, and rubella vaccine
03
Conditions
measles
Beyond the preview
Go deeper on NL-OMON44694.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44694.